-
EP1317929
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1317929
| EP1317929 - Combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis c infection [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 03.08.2007 Database last updated on 21.01.2025 | Most recent event Tooltip | 03.08.2007 | Application deemed to be withdrawn | published on 05.09.2007 [2007/36] | Applicant(s) | For all designated states Schering Corporation 2000 Galloping Hill Road Kenilworth, NJ 07033 / US | [N/P] |
| Former [2003/24] | For all designated states SCHERING CORPORATION 2000 Galloping Hill Road Kenilworth New Jersey 07033 / US | Inventor(s) | 01 /
Albrecht, Janice K. 1308 Temple Grove Court Winter Park, Florida 32789 / US | [2003/24] | Representative(s) | Adams, Harvey Vaughan John, et al Mathys & Squire LLP The Shard 32 London Bridge Street London SE1 9SG / GB | [N/P] |
| Former [2007/01] | Adams, Harvey Vaughan John, et al Mathys & Squire 120 Holborn London EC1N 2SQ / GB | ||
| Former [2003/24] | Ritter, Stephen David, et al Mathys & Squire 100 Gray's Inn Road London WC1X 8AL / GB | Application number, filing date | 02026486.7 | 07.08.1998 | [2003/24] | Priority number, date | US19970938033 | 21.09.1997 Original published format: US 938033 | US19970935123 | 22.09.1997 Original published format: US 935123 | [2003/24] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP1317929 | Date: | 11.06.2003 | Language: | EN | [2003/24] | Type: | A3 Search report | No.: | EP1317929 | Date: | 02.07.2003 | [2003/27] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 16.05.2003 | Classification | IPC: | A61K38/21, A61P31/14, // (A61K38/21, 31:7056) | [2003/27] | CPC: |
A61K38/212 (EP);
A61K38/21 (KR);
A61K31/70 (KR);
A61P1/00 (EP);
A61P1/16 (EP);
A61P31/00 (EP);
A61P31/12 (EP);
A61P31/14 (EP);
A61P43/00 (EP);
A61K38/00 (EP)
(-)
| C-Set: |
A61K38/212, A61K2300/00 (EP)
|
| Former IPC [2003/24] | A61K38/21, A61P31/14 | Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2003/24] | Extension states | LT | 28.11.2002 | LV | 28.11.2002 | RO | 28.11.2002 | Title | German: | Kombinationstherapie zur Entfernung von nachweisbarer HCV-RNS in Patienten mit chronischer Hepatitis C-Infektion | [2003/24] | English: | Combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis c infection | [2003/24] | French: | Thérapie combinée pour l'éradication de l' HCV-ARN détectable chez des patients atteints d'une infection d'hépatite C chronique | [2003/24] | Examination procedure | 28.11.2002 | Examination requested [2003/24] | 06.11.2006 | Despatch of a communication from the examining division (Time limit: M04) | 17.03.2007 | Application deemed to be withdrawn, date of legal effect [2007/36] | 20.04.2007 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2007/36] | Parent application(s) Tooltip | EP01113628.0 / EP1136075 | EP98306332.2 / EP0903148 | Fees paid | Renewal fee | 28.11.2002 | Renewal fee patent year 03 | 28.11.2002 | Renewal fee patent year 04 | 28.11.2002 | Renewal fee patent year 05 | 06.08.2003 | Renewal fee patent year 06 | 06.08.2004 | Renewal fee patent year 07 | 08.08.2005 | Renewal fee patent year 08 | 07.08.2006 | Renewal fee patent year 09 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [DX]EP0707855 (SCHERING CORP [US]) [DX] 1-18 * the whole document *; | [DX] - R. SCHVARCZ ET AL., "COMBINATION TREATMENT WITH INTERFERON ALPHA-2b AND RIBAVIRIN FOR CHRONIC HEPATITIS C IN PATIENTS WHO HAVE FAILED TO ACHIEVE SUSTAINED RESPONSE TO INTERFERON ALONE: SWEDISH EXPERIENCE.", JOURNAL OF HEPATOLOGY, COPENHAGEN, DK, (1995), vol. 23, no. SUPPL. 2, pages 17 - 21, XP002094474 [DX] 1-18 * the whole document * | [DX] - R. SCHVARCZ ET AL., "COMBINED TREATMENT WITH INTERFERON ALPHA-2b AND RIBAVIRIN FOR CHRONIC HEPATITIS C IN PATIENTS WITH A PREVIOUS NON-RESPONSE OR NON-SUSTAINED RESPONSE TO INTERFERON ALONE", JOURNAL OF MEDICAL VIROLOGY, (199505), vol. 46, no. 1, pages 43 - 47, XP000600936 [DX] 1-18 * the whole document * DOI: http://dx.doi.org/10.1002/jmv.1890460110 | [DX] - J.T. BROUWER ET AL., "WHAT OPTIONS ARE LEFT WHEN HEPATITIS C DOES NOT RESPOND TO INTERFERON? PLACEBO-CONTROLLED BENELUX MULTICENTRE RETREATMENT TRIAL ON RIBAVIRIN MONOTHERAPY VERSUS COMBINATION WITH INTERFERON.", JOURNAL OF HEPATOLOGY, COPENHAGEN, DK, (1994), vol. 21, no. SUPPL. 1, page S17, XP002094475 [DX] 1-18 * abstract nr. WP2/08 * | [DX] - L. CHEMELLO ET AL., "RESPONSE TO RIBAVIRIN, TO INTERFERON AND TO A COMBINATION OF BOTH IN PATIENTS WITH CHRONIC HEPATITIS C AND ITS RELATION TO HCV GENOTYPES.", JOURNAL OF HEPATOLOGY, COPENHAGEN, DK, (1994), vol. 21, no. SUPPL. 1, page S12, XP002094476 [DX] 1-18 * abstract nr. GS5/29 * | [DX] - S. BRILLANTI ET AL., "A PILOT STUDY OF COMBINATION THERAPY WITH RIBAVIRIN PLUS INTERFERON ALFA FOR INTERFERON ALFA-RESISTANT CHRONIC HEPATITIS C.", GASTROENTEROLOGY, (199409), vol. 107, no. 3, pages 812 - 817, XP000600924 [DX] 1-18 * the whole document * | [DX] - J.H. BRACONIER ET AL., "COMBINED ALPHA-INTERFERON AND RIBAVIRIN TREATMENT IN CHRONIC HEPATITIS C: A PILOT STUDY", SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, (1995), vol. 27, no. 4, pages 325 - 329, XP000600916 [DX] 1-18 * the whole document * |